Clinical significance of anti-DFS70 in immunoinflammatory rheumatic diseases (review)-Reference-Cited by-同舟云学术

Clinical significance of anti-DFS70 in immunoinflammatory rheumatic diseases (review)

Published:2023-03-05 Issue:1 Volume:61 Page:100-105
ISSN:1995-4492
Container-title:Rheumatology Science and Practice
language:
Short-container-title:Naučno-praktičeskaâ revmatologiâ

Author:

Panafidina T. A.¹^ORCID,Verizhnikova Zh. G.¹^ORCID,Avdeeva A. S.¹^ORCID,Popkova T. V.¹^ORCID,Nasonov E. L.²^ORCID

Affiliation:

1. V.A. Nasonova Research Institute of Rheumatology

2. V.A. Nasonova Research Institute of Rheumatology; I.M. Sechenov First Moscow State Medical University of the Ministry of Health Care of Russian Federation (Sechenov University)

Abstract

The relevance of the problem of immunoinflammatory rheumatic diseases (IIRD) for modern medicine is determined by their high prevalence in the population, the difficulty of early diagnosis, the rapid development of disability and poor life prognosis. Recent data on the significance of anti-DFS70 have opened up new possibilities for optimizing the step-by-step diagnosis of IIRD. The detection of these antibodies can help in the interpretation of a positive result for antinuclear antibodies (ANA) by indirect immunofluorescence assay on HEp-2 cells (IIFA-HEp-2) in the absence of autoantibodies specific for IIRD. Detection of anti-DFS70 in antinuclear factor (ANF) seropositive patients without clinical and/or serological markers characteristic of a certain disease from the IIRD group can be considered as a potential marker that excludes this group of diseases.

Publisher

Mediar Press

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference54 articles.

1. Goldblatt F, O’Neill SG. Clinical aspects of autoimmune rheumatic diseases. Lancet. 2013;382(9894):797-808. doi: 10.1016/S0140-6736(13)61499-3

2. Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001;345(5):340-350. doi: 10.1056/NEJM200108023450506

3. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725. doi: 10.1002/art.1780400928

4. Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677-2686. doi: 10.1002/art.34473

5. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9): 1151-1159. doi: 10.1136/annrheumdis-2018-214819

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Anti-DFS70 in the Diagnosis of Systemic Autoimmune Rheumatic Diseases;Biologics;2023-11-14